A substantial percentage of adults with gout attribute their condition to lifestyle factors, which may lead to worse health outcomes and poorer SU control.

In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases ...

The latest announcement is out from XORTX Therapeutics Inc ( ($TSE:XRTX) ). On December 31, 2025, XORTX Therapeutics highlighted newly published, ...

XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...

WASHINGTON — Take the generic drug clonidine for high blood pressure? Double-check that you didn't leave the drugstore with Klonopin for seizures, or the gout medicine colchicine. Mixing up drug names ...

SEMDEXA (TM) (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido (R) is a ...

Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire ...

Videos focused mainly on healthy diet and cutting back on alcohol, which has limited long-term effectiveness in managing gout Few videos mentioned drugs to lower uric acid levels or reduce ...

This is Everyday Science with Clare Wilson, a subscriber-only newsletter from The i Paper. If you’d like to get this direct to your inbox every week, y ou can sign up here. Hello, and welcome back to ...